Syndax Pharmaceuticals (SNDX) Asset Utilization Ratio (2016 - 2026)

Syndax Pharmaceuticals' Asset Utilization Ratio history runs 10 years deep, the most recent figure standing at 0.43 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio rose 577.44% year-over-year to 0.43 in Q1 2026; TTM through Mar 2026 was 0.43, a 577.44% increase from a year earlier, with the FY2025 full-year figure at 0.27, up 676.09% from the prior year.
• Asset Utilization Ratio improved to 0.43 in Q1 2026 per SNDX's latest filing, from 0.32 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.43 in Q1 2026 and bottomed at 0.01 in Q2 2024.
• The 4-year median for Asset Utilization Ratio is 0.19 (2025), against an average of 0.19.
• Across the five-year window, Asset Utilization Ratio plunged 97.81% in 2024 and surged 1742.04% in 2025, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.25 in 2023, then slumped by 83.54% to 0.04 in 2024, then surged by 675.47% to 0.32 in 2025, then soared by 35.91% to 0.43 in 2026.
• Per Business Quant, the three latest SNDX Asset Utilization Ratio figures stand at 0.43 (Q1 2026), 0.32 (Q4 2025), and 0.19 (Q3 2025).